JP5088894B2 - 生体適合性組織封止剤および接着剤 - Google Patents
生体適合性組織封止剤および接着剤 Download PDFInfo
- Publication number
- JP5088894B2 JP5088894B2 JP2008544473A JP2008544473A JP5088894B2 JP 5088894 B2 JP5088894 B2 JP 5088894B2 JP 2008544473 A JP2008544473 A JP 2008544473A JP 2008544473 A JP2008544473 A JP 2008544473A JP 5088894 B2 JP5088894 B2 JP 5088894B2
- Authority
- JP
- Japan
- Prior art keywords
- diisocyanate
- composition
- biocompatible
- functionalized
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000565 sealant Substances 0.000 title claims description 65
- 239000000853 adhesive Substances 0.000 title claims description 54
- 230000001070 adhesive effect Effects 0.000 title claims description 54
- 239000000203 mixture Substances 0.000 claims description 152
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims description 36
- 229920005862 polyol Polymers 0.000 claims description 29
- 150000003077 polyols Chemical class 0.000 claims description 29
- 239000012948 isocyanate Substances 0.000 claims description 23
- 150000002513 isocyanates Chemical group 0.000 claims description 23
- 150000001412 amines Chemical class 0.000 claims description 22
- 150000002009 diols Chemical class 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 17
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 16
- -1 polypropylene Polymers 0.000 claims description 15
- 239000004971 Cross linker Substances 0.000 claims description 14
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 229920001451 polypropylene glycol Polymers 0.000 claims description 11
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 10
- 150000008064 anhydrides Chemical group 0.000 claims description 10
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 9
- 125000005442 diisocyanate group Chemical group 0.000 claims description 8
- 229920001610 polycaprolactone Polymers 0.000 claims description 8
- 239000004632 polycaprolactone Substances 0.000 claims description 8
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical group CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 claims description 8
- 150000004072 triols Chemical class 0.000 claims description 7
- FKTHNVSLHLHISI-UHFFFAOYSA-N 1,2-bis(isocyanatomethyl)benzene Chemical compound O=C=NCC1=CC=CC=C1CN=C=O FKTHNVSLHLHISI-UHFFFAOYSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 6
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 6
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 229920003232 aliphatic polyester Chemical group 0.000 claims description 5
- 150000004982 aromatic amines Chemical class 0.000 claims description 5
- 150000004649 carbonic acid derivatives Chemical group 0.000 claims description 5
- 239000003431 cross linking reagent Substances 0.000 claims description 5
- 150000004985 diamines Chemical class 0.000 claims description 5
- 150000002576 ketones Chemical group 0.000 claims description 5
- AYLRODJJLADBOB-QMMMGPOBSA-N methyl (2s)-2,6-diisocyanatohexanoate Chemical compound COC(=O)[C@@H](N=C=O)CCCCN=C=O AYLRODJJLADBOB-QMMMGPOBSA-N 0.000 claims description 5
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 5
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 claims description 4
- KDLIYVDINLSKGR-UHFFFAOYSA-N 1-isocyanato-4-(4-isocyanatophenoxy)benzene Chemical compound C1=CC(N=C=O)=CC=C1OC1=CC=C(N=C=O)C=C1 KDLIYVDINLSKGR-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000005058 Isophorone diisocyanate Substances 0.000 claims description 4
- 150000001298 alcohols Chemical group 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 4
- YOURXVGYNVXQKT-UHFFFAOYSA-N oxacycloundecane-2,11-dione Chemical compound O=C1CCCCCCCCC(=O)O1 YOURXVGYNVXQKT-UHFFFAOYSA-N 0.000 claims description 4
- LJAGLQVRUZWQGK-UHFFFAOYSA-N oxecane-2,10-dione Chemical compound O=C1CCCCCCCC(=O)O1 LJAGLQVRUZWQGK-UHFFFAOYSA-N 0.000 claims description 4
- 229920000768 polyamine Polymers 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- NNOZGCICXAYKLW-UHFFFAOYSA-N 1,2-bis(2-isocyanatopropan-2-yl)benzene Chemical compound O=C=NC(C)(C)C1=CC=CC=C1C(C)(C)N=C=O NNOZGCICXAYKLW-UHFFFAOYSA-N 0.000 claims description 3
- AQSVMUCTNYYCRW-UHFFFAOYSA-N 1,2-bis(isocyanatomethyl)-3,4,5-trimethylbenzene Chemical class CC1=CC(CN=C=O)=C(CN=C=O)C(C)=C1C AQSVMUCTNYYCRW-UHFFFAOYSA-N 0.000 claims description 3
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 claims description 3
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 claims description 3
- ATOUXIOKEJWULN-UHFFFAOYSA-N 1,6-diisocyanato-2,2,4-trimethylhexane Chemical compound O=C=NCCC(C)CC(C)(C)CN=C=O ATOUXIOKEJWULN-UHFFFAOYSA-N 0.000 claims description 3
- LFSYUSUFCBOHGU-UHFFFAOYSA-N 1-isocyanato-2-[(4-isocyanatophenyl)methyl]benzene Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=CC=C1N=C=O LFSYUSUFCBOHGU-UHFFFAOYSA-N 0.000 claims description 3
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 3
- OSVNEGAPNXBADJ-UHFFFAOYSA-N 2,4-diisocyanato-1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=C(N=C=O)C(C)=C1N=C=O OSVNEGAPNXBADJ-UHFFFAOYSA-N 0.000 claims description 3
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 claims description 3
- OMRDSWJXRLDPBB-UHFFFAOYSA-N N=C=O.N=C=O.C1CCCCC1 Chemical compound N=C=O.N=C=O.C1CCCCC1 OMRDSWJXRLDPBB-UHFFFAOYSA-N 0.000 claims description 3
- INWVTRVMRQMCCM-UHFFFAOYSA-N N=C=O.N=C=O.C=1C=CC=CC=1C(C)(C)C1=CC=CC=C1 Chemical compound N=C=O.N=C=O.C=1C=CC=CC=1C(C)(C)C1=CC=CC=C1 INWVTRVMRQMCCM-UHFFFAOYSA-N 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 239000001361 adipic acid Substances 0.000 claims description 3
- 235000011037 adipic acid Nutrition 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 3
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 3
- 229920000083 poly(allylamine) Polymers 0.000 claims description 3
- 150000003141 primary amines Chemical class 0.000 claims description 3
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 claims description 3
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 3
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 2
- 229940008841 1,6-hexamethylene diisocyanate Drugs 0.000 claims description 2
- YZBOZNXACBQJHI-UHFFFAOYSA-N 1-dichlorophosphoryloxyethane Chemical compound CCOP(Cl)(Cl)=O YZBOZNXACBQJHI-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- HIFVAOIJYDXIJG-UHFFFAOYSA-N benzylbenzene;isocyanic acid Chemical class N=C=O.N=C=O.C=1C=CC=CC=1CC1=CC=CC=C1 HIFVAOIJYDXIJG-UHFFFAOYSA-N 0.000 claims 2
- 239000004952 Polyamide Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 54
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 239000012530 fluid Substances 0.000 description 8
- 239000007943 implant Substances 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000004721 Polyphenylene oxide Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 4
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 150000002596 lactones Chemical class 0.000 description 4
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 4
- 229920000570 polyether Polymers 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 239000004830 Super Glue Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000005056 polyisocyanate Substances 0.000 description 3
- 229920001228 polyisocyanate Polymers 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000003106 tissue adhesive Substances 0.000 description 3
- AGJCSCSSMFRMFQ-UHFFFAOYSA-N 1,4-bis(2-isocyanatopropan-2-yl)benzene Chemical compound O=C=NC(C)(C)C1=CC=C(C(C)(C)N=C=O)C=C1 AGJCSCSSMFRMFQ-UHFFFAOYSA-N 0.000 description 2
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- OTBHHUPVCYLGQO-UHFFFAOYSA-N bis(3-aminopropyl)amine Chemical class NCCCNCCCN OTBHHUPVCYLGQO-UHFFFAOYSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- YMHQVDAATAEZLO-UHFFFAOYSA-N cyclohexane-1,1-diamine Chemical class NC1(N)CCCCC1 YMHQVDAATAEZLO-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229920001002 functional polymer Polymers 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- 229920000962 poly(amidoamine) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920005906 polyester polyol Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 239000003894 surgical glue Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- AHBNSOZREBSAMG-UHFFFAOYSA-N 1,5-diisocyanato-2-methylpentane Chemical compound O=C=NCC(C)CCCN=C=O AHBNSOZREBSAMG-UHFFFAOYSA-N 0.000 description 1
- DTLIXPLJFCRLJY-UHFFFAOYSA-N 1-(1-aminocyclooctyl)cyclooctan-1-amine Chemical compound C1CCCCCCC1(N)C1(N)CCCCCCC1 DTLIXPLJFCRLJY-UHFFFAOYSA-N 0.000 description 1
- WTFAGPBUAGFMQX-UHFFFAOYSA-N 1-[2-[2-(2-aminopropoxy)propoxy]propoxy]propan-2-amine Chemical compound CC(N)COCC(C)OCC(C)OCC(C)N WTFAGPBUAGFMQX-UHFFFAOYSA-N 0.000 description 1
- WDWSPXNEUOSAHV-UHFFFAOYSA-N 1-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propan-2-amine Chemical compound CC(N)COCCOCCOCCCN WDWSPXNEUOSAHV-UHFFFAOYSA-N 0.000 description 1
- WCDFMPVITAWTGR-UHFFFAOYSA-N 1-imidazol-1-ylpropan-2-ol Chemical compound CC(O)CN1C=CN=C1 WCDFMPVITAWTGR-UHFFFAOYSA-N 0.000 description 1
- AYORTOFSIKLNIK-UHFFFAOYSA-N 1-n-[2-(dimethylamino)ethyl]-2-n,2-n-dimethylpropane-1,2-diamine Chemical compound CN(C)C(C)CNCCN(C)C AYORTOFSIKLNIK-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical class NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 1
- GTEXIOINCJRBIO-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]-n,n-dimethylethanamine Chemical compound CN(C)CCOCCN(C)C GTEXIOINCJRBIO-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- GPLIMIJPIZGPIF-UHFFFAOYSA-N 2-hydroxy-1,4-benzoquinone Chemical compound OC1=CC(=O)C=CC1=O GPLIMIJPIZGPIF-UHFFFAOYSA-N 0.000 description 1
- FEUISMYEFPANSS-UHFFFAOYSA-N 2-methylcyclohexan-1-amine Chemical compound CC1CCCCC1N FEUISMYEFPANSS-UHFFFAOYSA-N 0.000 description 1
- RXFCIXRFAJRBSG-UHFFFAOYSA-N 3,2,3-tetramine Chemical class NCCCNCCNCCCN RXFCIXRFAJRBSG-UHFFFAOYSA-N 0.000 description 1
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 description 1
- YOOSAIJKYCBPFW-UHFFFAOYSA-N 3-[4-(3-aminopropoxy)butoxy]propan-1-amine Chemical compound NCCCOCCCCOCCCN YOOSAIJKYCBPFW-UHFFFAOYSA-N 0.000 description 1
- LNWUNIOANJTGPG-UHFFFAOYSA-N 3-chloro-3h-2,1$l^{6}-benzoxathiole 1,1-dioxide Chemical compound C1=CC=C2C(Cl)OS(=O)(=O)C2=C1 LNWUNIOANJTGPG-UHFFFAOYSA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- JIGUICYYOYEXFS-UHFFFAOYSA-N 3-tert-butylbenzene-1,2-diol Chemical compound CC(C)(C)C1=CC=CC(O)=C1O JIGUICYYOYEXFS-UHFFFAOYSA-N 0.000 description 1
- WECDUOXQLAIPQW-UHFFFAOYSA-N 4,4'-Methylene bis(2-methylaniline) Chemical compound C1=C(N)C(C)=CC(CC=2C=C(C)C(N)=CC=2)=C1 WECDUOXQLAIPQW-UHFFFAOYSA-N 0.000 description 1
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical class C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- ZYEDGEXYGKWJPB-UHFFFAOYSA-N 4-[2-(4-aminophenyl)propan-2-yl]aniline Chemical compound C=1C=C(N)C=CC=1C(C)(C)C1=CC=C(N)C=C1 ZYEDGEXYGKWJPB-UHFFFAOYSA-N 0.000 description 1
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004178 Cathepsin E Human genes 0.000 description 1
- 108090000611 Cathepsin E Proteins 0.000 description 1
- 108090000617 Cathepsin G Proteins 0.000 description 1
- 102000004173 Cathepsin G Human genes 0.000 description 1
- 102000004175 Cathepsin H Human genes 0.000 description 1
- 108090000619 Cathepsin H Proteins 0.000 description 1
- 102000004172 Cathepsin L Human genes 0.000 description 1
- 108090000624 Cathepsin L Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical class NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 102100030011 Endoribonuclease Human genes 0.000 description 1
- 108010093099 Endoribonucleases Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- SVYKKECYCPFKGB-UHFFFAOYSA-N N,N-dimethylcyclohexylamine Chemical compound CN(C)C1CCCCC1 SVYKKECYCPFKGB-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 239000004826 Synthetic adhesive Substances 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000013466 adhesive and sealant Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005360 alkyl sulfoxide group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- MRNZSTMRDWRNNR-UHFFFAOYSA-N bis(hexamethylene)triamine Chemical class NCCCCCCNCCCCCCN MRNZSTMRDWRNNR-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- WVPKAWVFTPWPDB-UHFFFAOYSA-N dichlorophosphinic acid Chemical compound OP(Cl)(Cl)=O WVPKAWVFTPWPDB-UHFFFAOYSA-N 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 229950010007 dimantine Drugs 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 239000012971 dimethylpiperazine Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- DTSDBGVDESRKKD-UHFFFAOYSA-N n'-(2-aminoethyl)propane-1,3-diamine Chemical class NCCCNCCN DTSDBGVDESRKKD-UHFFFAOYSA-N 0.000 description 1
- YWWNNLPSZSEZNZ-UHFFFAOYSA-N n,n-dimethyldecan-1-amine Chemical compound CCCCCCCCCCN(C)C YWWNNLPSZSEZNZ-UHFFFAOYSA-N 0.000 description 1
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 description 1
- NHLUVTZJQOJKCC-UHFFFAOYSA-N n,n-dimethylhexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCN(C)C NHLUVTZJQOJKCC-UHFFFAOYSA-N 0.000 description 1
- SFBHPFQSSDCYSL-UHFFFAOYSA-N n,n-dimethyltetradecan-1-amine Chemical compound CCCCCCCCCCCCCCN(C)C SFBHPFQSSDCYSL-UHFFFAOYSA-N 0.000 description 1
- OLAKSHDLGIUUET-UHFFFAOYSA-N n-anilinosulfanylaniline Chemical compound C=1C=CC=CC=1NSNC1=CC=CC=C1 OLAKSHDLGIUUET-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229940066734 peptide hydrolases Drugs 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002721 polycyanoacrylate Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- VHNQIURBCCNWDN-UHFFFAOYSA-N pyridine-2,6-diamine Chemical compound NC1=CC=CC(N)=N1 VHNQIURBCCNWDN-UHFFFAOYSA-N 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- MBDNRNMVTZADMQ-UHFFFAOYSA-N sulfolene Chemical compound O=S1(=O)CC=CC1 MBDNRNMVTZADMQ-UHFFFAOYSA-N 0.000 description 1
- 150000008053 sultones Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- RJSZFSOFYVMDIC-UHFFFAOYSA-N tert-butyl n,n-dimethylcarbamate Chemical compound CN(C)C(=O)OC(C)(C)C RJSZFSOFYVMDIC-UHFFFAOYSA-N 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical class NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 1
- 229940075469 tissue adhesives Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/4804—Two or more polyethers of different physical or chemical nature
- C08G18/4812—Mixtures of polyetherdiols with polyetherpolyols having at least three hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/62—Polymers of compounds having carbon-to-carbon double bonds
- C08G18/6212—Polymers of alkenylalcohols; Acetals thereof; Oxyalkylation products thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/65—Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
- C08G18/66—Compounds of groups C08G18/42, C08G18/48, or C08G18/52
- C08G18/6666—Compounds of group C08G18/48 or C08G18/52
- C08G18/667—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38
- C08G18/6681—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J175/00—Adhesives based on polyureas or polyurethanes; Adhesives based on derivatives of such polymers
- C09J175/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2190/00—Compositions for sealing or packing joints
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Surgical Instruments (AREA)
Description
この出願は、2005年12月6日に出願された米国仮特許出願第60/742,939号(この全体の開示が本明細書に参考として援用される)の利益を主張する。
本開示は、インビボの動物組織での医療使用および外科使用のための合成成分から形成された接着剤または封止剤に関する。
近年、縫合を接着剤ボンドで代用または増強することに関心が高まっている。関心が高まった理由として(1)修復が成功し得る潜在的な速度;(2)完全閉鎖をもたらす結合物質の能力、つまり流体の漏出を防ぐ能力;および(3)組織が異常変形することなしに接合を形成する可能性が挙げられる。
本開示の組成物は、医療用途/外科用途の合成接着剤および封止剤に関する。本生体適合性接着剤組成物は、官能化トリオールと官能化ジオールとを含み、一方、本封止剤組成物は、多官能ポリオールと少なくとも1つのアミン架橋剤とをさらに含む。特に有用な実施態様では、トリオールおよびジオールは、複数のイソシアナート基を有するポリアルキレンオキシドで官能化されていてよい。
式
[X−Y−X−O]3−R
の官能化トリオールと、
式
[X−Y−X−O]2−R
の官能化ジオールとを含む生体適合性接着剤を含んでよい。式中、
Xはイソシアネートであり、Yはポリアルキレンオキシドであり、Rはアルコール、脂肪族ポリエステル、ケトン、炭酸エステル、無水物およびそれらの組み合わせであってよい。
[X−Y−X−O]3−R
の官能化トリオール、
式
[X−Y−X−O]2−R
の官能化ジオール、
多官能性アルコール、および
少なくとも1つのアミン架橋剤を含む生体適合性封止剤を含んでよい。式中、Xはイソシアネートであり、Yはポリアルキレンオキシドであり、Rはアルコール、脂肪族ポリエステル、ケトン、炭酸エステル、無水物およびそれらの組み合わせであってよい。実施態様によっては、多官能性アルコールは、式
E−X−Z−[(D)w−X]r
であってよい。式中、Eは親水性重合体であり、Xはそれぞれの位置で同じであってよくまたは異なっていてよく、イソシアネートであり、Zはポリオールであり、Dは生体吸収性基であり、wは1から20の数であり、rは1から10の数である。適当なアミン架橋剤は、第一アミン、ジアミン、芳香族アミン、ポリアミンおよびポリアミドアミンを含む。
本開示は、組織接着剤または封止剤として用いるための生体適合性組成物に関する。本生体適合性組成物は、生体適合性であり、非免疫原性であり、生分解性である。本生体適合性組成物は、組織端を接着させ、医療デバイス(すなわちインプラント)を組織に接着させ、組織中の空気/流体漏れを封止するため、および組織中の空洞または欠陥を封止または充填するなどの組織増強のために使用することができる。従って、本明細書で用いられる「接着剤」とは、組織端を互いに、またはインプラントなどのデバイスを組織になど、1つのものを別のものに接着させる組成物を意味すると理解され、「封止剤」とは、組織に塗布され、組織中の空気/流体漏れを封止するため、または組織中の小さな空洞または欠陥を封止または充填するために利用される組成物を意味すると理解される。生体適合性組成物は、生体組織および/またはヒトを含む動物の肉体に塗布することができる。
[X−Y−X−O]3−R (I)
の官能化トリオールを生成させてよい。式中、Xは同じであっても異なっていてもよく、ポリイソシアネートを含むイソシアネートであり、Yはポリアルキレンオキシドであってよく、Rはアルコール、脂肪族ポリエステル、ケトン、炭酸エステル、無水物またはそれらの組み合わせであってよい。実施態様によっては、Xはヘキサメチレンジイソシアネートであり、Yはポリエチレングリコールであり、Rはポリカプロラクトンなどのラクトンである。
[X−Y−X−O]2−R (II)
の基本構造を有してよい。式中、X、YおよびRは上記で定義したと同じである。実施態様によっては、Xはヘキサメチレンジイソシアネートなどのイソシアネートであり、Yはポリエチレングリコールであり、Rはポリカプロラクトンである。
E−X−Z−[(D)w−X]r (III)
の化合物を形成する。式中、Eは親水性重合体であり、Xは各位置で同じであってよくまたは異なっていてよく、上記に記載したイソシアネートであり、Zはポリオール成分であり、Dは生体吸収性基であり、wは1から20の数であり、rは1から10の数である。特に有用な実施態様では、Eはポリエチレングリコールであり、Xはヘキサメチレンジイソシアネートであり、ZはD−ソルビトールであり、Dはラクチドであり、wは2から10の数であり、rは2から5の数である。
Claims (22)
- 式
[X−Y−X−O]3−R (I)
の官能化トリオールと、
式
[X−Y−X−O]2−R (II)
の官能化ジオールと
を含む生体適合性接着剤組成物であって、
Xはイソシアネートであり、Yはポリアルキレンオキシドであり、Rはアルコール、脂肪族ポリエステル、ケトン、炭酸エステル、無水物およびそれらの組み合わせからなる群より選択され、
Rは、ポリカプロラクトンを含む、
生体適合性接着剤組成物。 - 前記イソシアネートは、2,4−トルエンジイソシアネート、2,6−トルエンジイソシアネート、2,2’−ジフェニルメタンジイソシアネート、2,4’−ジフェニルメタンジイソシアネート、4,4’−ジフェニルメタンジイソシアネート、ジフェニルジメチルメタンジイソシアネート、ジベンジルジイソシアネート、ナフチレンジイソシアネート、フェニレンジイソシアネート、キシリレンジイソシアネート、4,4’−オキシビス(フェニルイソシアネート)、2,4,6−トリメチル−1,3−フェニレンジイソシアネート、テトラメチルキシリレンジイソシアネート、テトラメチレンジイソシアネート、ヘキサメチレンジイソシアネート、リジンジイソシアネート、2−メチルペンタン-1,5−
ジイソシアネート、3−メチルペンタン−1,5−ジイソシアネート、2,2,4−トリメチルヘキサメチレンジイソシアネート、イソホロンジイソシアネート、シクロヘキサンジイソシアネート、水素化キシリレンジイソシアネート、水素化ジフェニルメタンジイソシアネートおよび水素化トリメチルキシリレンジイソシアネートからなる群より選択される、請求項1に記載の生体適合性接着剤組成物。 - 前記ポリアルキレンオキシドは、ポリエチレングリコール、ポリエチレンオキシド、ポリプロピレンオキシド、ポリプロピレングリコール−co−ポリエチレンオキシド共重合体、およびポリプロピレンオキシドとのポリエチレンオキシド共重合体からなる群より選択される、請求項1に記載の生体適合性接着剤組成物。
- 前記ポリアルキレンオキシドは、ポリエチレングリコールを含む、請求項1に記載の生体適合性接着剤組成物。
- 前記組成物の10から98重量パーセントの量の前記官能化ジオールが存在し、該組成物の90から2重量パーセントの量の前記官能化トリオールが存在する、請求項1に記載の生体適合性接着剤組成物。
- 式
[X−Y−X−O]3−R (I)
の官能化トリオール、
式
[X−Y−X−O]2−R (II)
の官能化ジオール、
多官能性アルコールおよび
少なくとも1つのアミン架橋剤
を含む、生体適合性封止剤組成物であって、
Xはイソシアネートであり、Yはポリアルキレンオキシドであり、Rはアルコール、脂肪族ポリエステル、ケトン、炭酸エステル、無水物およびそれらの組み合わせからなる群より選択され、
Rは、ポリカプロラクトンを含む、
生体適合性封止剤組成物。 - 前記イソシアネートは、2,4−トルエンジイソシアネート、2,6−トルエンジイソシアネート、2,2’−ジフェニルメタンジイソシアネート、2,4’−ジフェニルメタンジイソシアネート、4,4’−ジフェニルメタンジイソシアネート、ジフェニルジメチルメタンジイソシアネート、ジベンジルジイソシアネート、ナフチレンジイソシアネート、フェニレンジイソシアネート、キシリレンジイソシアネート、4,4’−オキシビス(フェニルイソシアネート)、2,4,6−トリメチル−1,3−フェニレンジイソシアネート、テトラメチルキシリレンジイソシアネート、テトラメチレンジイソシアネート、ヘキサメチレンジイソシアネート、リジンジイソシアネート、2−メチルペンタン-1,5−
ジイソシアネート、3−メチルペンタン−1,5−ジイソシアネート、2,2,4−トリメチルヘキサメチレンジイソシアネート、イソホロンジイソシアネート、シクロヘキサンジイソシアネート、水素化キシリレンジイソシアネート、水素化ジフェニルメタンジイソシアネートおよび水素化トリメチルキシリレンジイソシアネートからなる群より選択される、請求項6に記載の生体適合性封止剤組成物。 - 前記ポリアルキレンオキシドは、ポリエチレングリコール、ポリエチレンオキシド、ポリプロピレンオキシド、ポリプロピレングリコール−co−ポリエチレンオキシド共重合体、およびポリプロピレンオキシドとのポリエチレンオキシド共重合体からなる群より選択される、請求項6に記載の生体適合性封止剤組成物。
- 前記ポリアルキレンオキシドは、ポリエチレングリコールを含む、請求項6に記載の生体適合性封止剤組成物。
- 前記多官能性アルコールは、ソルビトール、グリセロール、ペンタエリスリトール、マンニトール、グルコース、デキストロース、スクロースおよびそれらの組み合わせからなる群より選択されたポリオールを含む、請求項6に記載の生体適合性封止剤組成物。
- 前記多官能性アルコールは、乳酸、グリコール酸、ヒドロキシ−酪酸、ポリヒドロキシ吉草酸、グリコリド、ラクチド、ε−カプロラクトン、炭酸トリメチレン、1,4−ジオキサン−2−オン、1,3−ジオキサン−2−オン、コハク酸、アジピン酸、セバシン酸、マロン酸、グルタル酸、アゼライン酸、ジクロロリン酸エチル、セバシン酸無水物、アゼライン酸無水物およびそれらの組み合わせからなる群より選択された生体吸収性基で官能化されている、請求項6に記載の生体適合性封止剤組成物。
- 前記多官能性アルコールの前記生物吸収性基は、トルエンジイソシアネート、4,4’−ジフェニルメタンジイソシアネート、1,6−ヘキサメチレンジイソシアネート、イソホロンジイソシアネート、4,4’−オキシビス(フェニルイソシアネート)およびリジンジイソシアネートからなる群より選択されたイソシアネートで末端を修飾されている、請求項11に記載の生体適合性封止剤組成物。
- 前記多官能性アルコールは、少なくとも1つの親水性重合体によってさらに官能化されている、請求項11に記載の生体適合性封止剤組成物。
- 前記少なくとも1つの親水性重合体は、ポリアルキレンオキシドを含む、請求項13に記載の生体適合性封止剤組成物。
- 前記多官能性アルコールは、式
E−X−Z−[(D)w−X]r (III)
であり、ここで
Eは親水性重合体であり、Xはそれぞれの位置で同じであっても異なっていてもよく、かつXはイソシアネートであり、Zはポリオールであり、Dは生物吸収性基であり、wは1から20の数であり、rは1から10の数である
請求項6に記載の生体適合性封止剤組成物。 - 前記親水性重合体はポリエチレングリコールを含み、前記イソシアネートはヘキサメチレンジイソシアネートを含み、前記多官能性アルコールはD−ソルビトールを含み、前記生物吸収性基はラクチドを含み、wは2から10の数であり、rは2から5の数である、請求項15に記載の生体適合性封止剤組成物。
- 前記少なくとも1つのアミン架橋剤は、第一アミン、ジアミン、芳香族アミン、ポリアミンおよびポリアミドアミンからなる群より選択される、請求項6に記載の生体適合性封止剤組成物。
- 前記少なくとも1つのアミン架橋剤は、ポリ(アリルアミン)、ポリ(L−リジン)および2つ以上のアミン官能基を有するポリアルキレンオキシドからなる群より選択される、請求項6に記載の生体適合性封止剤組成物。
- 前記官能化トリオールは前記組成物の1から50重量パーセントの量で存在し、前記官能化ジオールは該組成物の97から48重量パーセントの量で存在し、前記多官能性アルコールは該組成物の1から25重量パーセントの量で存在し、前記少なくとも1つのアミン架橋剤は該組成物の1から50重量パーセントの量で存在する、請求項6に記載の生体適合性封止剤組成物。
- 創傷を閉鎖するための請求項1に記載の生体適合性接着剤組成物であって、
該組成物は、該創傷に塗布されて硬化し、それによって該創傷を閉鎖することを特徴とする、組成物。 - 動物組織内の漏れを封止するための請求項7に記載の生体適合性封止剤組成物であって、
該組成物は、該漏れに塗布されて硬化し、それによって該漏れを封止させることを特徴とする、組成物。 - 医療デバイスを動物組織の表面へ接着させるための請求項1に記載の生体適合性接着剤組成物であって、
該組成物は、該デバイス、該表面または両方に塗布され、
該デバイス、生体適合性接着剤組成物および表面が互いに接触され、そして
該生体適合性封止剤組成物が硬化され、それによって該デバイスと表面とを互いに接着させることを特徴とする、組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74293905P | 2005-12-06 | 2005-12-06 | |
US60/742,939 | 2005-12-06 | ||
PCT/US2006/046554 WO2007067623A2 (en) | 2005-12-06 | 2006-12-06 | Biocompatible tissue sealants and adhesives |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009518128A JP2009518128A (ja) | 2009-05-07 |
JP2009518128A5 JP2009518128A5 (ja) | 2010-11-25 |
JP5088894B2 true JP5088894B2 (ja) | 2012-12-05 |
Family
ID=38123457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008544473A Expired - Fee Related JP5088894B2 (ja) | 2005-12-06 | 2006-12-06 | 生体適合性組織封止剤および接着剤 |
Country Status (6)
Country | Link |
---|---|
US (1) | US7998466B2 (ja) |
EP (1) | EP1968617A4 (ja) |
JP (1) | JP5088894B2 (ja) |
AU (1) | AU2006321913B2 (ja) |
CA (1) | CA2628582C (ja) |
WO (1) | WO2007067623A2 (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
CA2595633C (en) | 2005-02-09 | 2013-11-19 | Ahmad R. Hadba | Synthetic sealants |
US8044234B2 (en) * | 2005-05-05 | 2011-10-25 | Tyco Healthcare Group Lp | Bioabsorbable surgical composition |
US20090177226A1 (en) * | 2005-05-05 | 2009-07-09 | Jon Reinprecht | Bioabsorbable Surgical Compositions |
US20100100124A1 (en) * | 2005-05-05 | 2010-04-22 | Tyco Healthcare Group Lp | Bioabsorbable surgical composition |
JP5485551B2 (ja) * | 2005-12-06 | 2014-05-07 | コヴィディエン リミテッド パートナーシップ | 生体吸収性化合物およびそれらを含む組成物 |
WO2007067621A2 (en) * | 2005-12-06 | 2007-06-14 | Tyco Healthcare Group Lp | Biocompatible surgical compositions |
JP2009518129A (ja) | 2005-12-06 | 2009-05-07 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 生体吸収性外科用組成物 |
JP2009518142A (ja) | 2005-12-08 | 2009-05-07 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 生体適合性外科用組成物 |
WO2008076407A2 (en) | 2006-12-15 | 2008-06-26 | Lifebond Ltd. | Gelatin-transglutaminase hemostatic dressings and sealants |
US8133484B2 (en) | 2006-12-15 | 2012-03-13 | Lifebond Ltd | Hemostatic materials and dressing |
US20080293910A1 (en) * | 2007-05-24 | 2008-11-27 | Tyco Healthcare Group Lp | Adhesive formulatiions |
US7858835B2 (en) | 2007-06-27 | 2010-12-28 | Tyco Healthcare Group Lp | Foam control for synthetic adhesive/sealant |
US8500947B2 (en) * | 2007-11-15 | 2013-08-06 | Covidien Lp | Speeding cure rate of bioadhesives |
US8263704B2 (en) | 2008-04-23 | 2012-09-11 | Tyco Healthcare Group Lp | Bioabsorbable surgical composition |
AU2009261559B2 (en) | 2008-06-18 | 2014-01-16 | Lifebond Ltd | Improved cross-linked compositions |
US8349987B2 (en) * | 2009-02-19 | 2013-01-08 | Covidien Lp | Adhesive formulations |
US20110015672A1 (en) * | 2009-07-17 | 2011-01-20 | Tyco Healthcare Group Lp | Method for Coating a Medical Device |
US20110066123A1 (en) | 2009-09-15 | 2011-03-17 | Aidan Marcus Tout | Medical dressings, systems, and methods employing sealants |
ES2551388T3 (es) | 2009-12-22 | 2015-11-18 | Lifebond Ltd | Modificación de agentes de entrecruzamiento enzimáticos para controlar las propiedades de las matrices entrecruzadas |
US9119605B2 (en) | 2010-05-06 | 2015-09-01 | Zimmer, Inc. | Synthetic polymer adhesives and methods for making, using and delivering the same |
AU2011287215B2 (en) | 2010-08-05 | 2015-09-10 | Lifebond Ltd. | Dry composition wound dressings and adhesives |
DE102012107535A1 (de) * | 2012-08-16 | 2014-02-20 | Bess Pro Gmbh | Bioresorbierbare Klebstoffe und deren Verwendung im medizinischen Bereich |
US10016454B2 (en) | 2012-12-04 | 2018-07-10 | Cohera Medical, Inc. | Silane-containing moisture-curable tissue sealant |
US9295752B1 (en) * | 2014-09-30 | 2016-03-29 | Covidien Lp | Bioadhesive for occluding vessels |
KR20200051727A (ko) * | 2017-09-06 | 2020-05-13 | 난양 테크놀러지컬 유니버시티 | 흡습성의 가교결합 코팅제 및 바이오접착제 |
BR112020022415A2 (pt) * | 2018-05-04 | 2021-03-09 | Advanced Medical Solutions Israel (Sealantis) Ltd | sistemas de reconstituição e mistura |
US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
CN114574140A (zh) * | 2022-04-22 | 2022-06-03 | 东北师范大学 | 一种具有可控性的聚合物胶黏剂及其制备方法 |
Family Cites Families (127)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB985144A (en) | 1962-03-27 | 1965-03-03 | Ici Ltd | Process for purification of isocyanate group-containing compounds |
DE2032297A1 (de) * | 1970-06-23 | 1971-12-30 | Schering Ag | Verfahren zum Verkleben von weichgemachten, chlorhaltigen Polymerisaten |
US3879493A (en) * | 1972-02-14 | 1975-04-22 | Cpc International Inc | Vapor permeable compositions |
US3903232A (en) * | 1973-10-09 | 1975-09-02 | Grace W R & Co | Dental and biomedical foams and method |
US3975550A (en) * | 1974-08-07 | 1976-08-17 | General Foods Corporation | Plastically deformable ready-to-use batter |
US4061662A (en) | 1975-08-28 | 1977-12-06 | W. R. Grace & Co. | Removal of unreacted tolylene diisocyanate from urethane prepolymers |
US4057535A (en) * | 1976-04-14 | 1977-11-08 | Tatyana Esperovna Lipatova | Adhesive for gluing together soft body tissues |
US4169175A (en) | 1976-06-14 | 1979-09-25 | W. R. Grace & Co. | Removal of unreacted tolylene diisocyanate from urethane prepolymers |
US4132839A (en) * | 1976-10-12 | 1979-01-02 | W. R. Grace & Co. | Biodegradable hydrophilic foams and method |
SE417975B (sv) * | 1977-09-20 | 1981-04-27 | Gambro Dialysatoren | Forfarande for katalytisk utherdning av polyuretanformmassor i vilket man sasom fysiologiskt fordragbar herdningskatalysator anvender sorbinsyra eller kanelsyra |
US4323491A (en) * | 1980-04-24 | 1982-04-06 | Veselovsky Roman A | Polyurethane adhesive composition |
AU558611B2 (en) * | 1981-02-03 | 1987-02-05 | Bayer Aktiengesellschaft | Polyurethane gel |
US4425472A (en) * | 1981-06-22 | 1984-01-10 | Lord Corporation | Radiation-curable compositions |
US4419476A (en) | 1981-10-09 | 1983-12-06 | E. I. Du Pont De Nemours & Co. | Ternary adhesive systems |
US4451627A (en) * | 1982-09-07 | 1984-05-29 | The Dow Chemical Company | Addition polymerizable urethane-based anaerobic adhesives made from tin (II) organoesters |
US4511626A (en) * | 1982-09-09 | 1985-04-16 | Minnesota Mining And Manufacturing Company | One-part moisture-curable polyurethane adhesive, coating, and sealant compositions |
US4477604A (en) * | 1982-09-20 | 1984-10-16 | Oechsle Iii Sixtus J | Polyurethane compositions and their use as luting agents |
DE3329392A1 (de) * | 1983-08-13 | 1985-02-28 | Bayer Ag, 5090 Leverkusen | Thermisch verformbares konstruktionsmaterial, verfahren zu dessen herstellung und dessen verwendung |
JPS60152535A (ja) * | 1984-01-20 | 1985-08-10 | Ichiro Shibauchi | 架橋剤及びその製造方法 |
JPS6147775A (ja) * | 1984-08-14 | 1986-03-08 | Dainippon Ink & Chem Inc | 複合ラミネ−トフイルム用接着剤組成物 |
JPS61152765A (ja) * | 1984-12-27 | 1986-07-11 | Nippon Ekishiyou Kk | シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法 |
US4740534A (en) * | 1985-08-30 | 1988-04-26 | Sanyo Chemical Industries, Ltd. | Surgical adhesive |
ES2043619T3 (es) * | 1986-05-14 | 1994-01-01 | Takiron Co | Adhesivo para administracion percutanea. |
JPH0739457B2 (ja) * | 1986-05-14 | 1995-05-01 | タキロン株式会社 | 両親媒性セグメントポリウレタン |
EP0280737B1 (en) * | 1986-08-20 | 1991-12-11 | Teikoku Seiyaku Co., Ltd. | Steroidal drug-containing preparation for external use |
US5169720A (en) * | 1986-11-18 | 1992-12-08 | W. R. Grace & Co.-Conn. | Protein non-adsorptive polyurea-urethane polymer coated devices |
US4829099A (en) * | 1987-07-17 | 1989-05-09 | Bioresearch, Inc. | Metabolically acceptable polyisocyanate adhesives |
AU608857B2 (en) | 1987-07-31 | 1991-04-18 | Mitsubishi Rayon Company Limited | Dental adhesive composition |
US4804691A (en) * | 1987-08-28 | 1989-02-14 | Richards Medical Company | Method for making a biodegradable adhesive for soft living tissue |
JP2691722B2 (ja) * | 1988-03-07 | 1997-12-17 | 旭硝子株式会社 | 外科用接着剤 |
US5065752A (en) * | 1988-03-29 | 1991-11-19 | Ferris Mfg. Co. | Hydrophilic foam compositions |
DE68911181T2 (de) * | 1988-03-31 | 1994-04-07 | Grace W R & Co | Mit Protein nichtabsorbierend polyureum-urethan-polymerbeschichtete Gegenstände. |
US4883837A (en) * | 1988-06-24 | 1989-11-28 | The Dow Chemical Company | Compatible blends of polyolefins with thermoplastic polyurethanes |
US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
EP0390481B1 (en) * | 1989-03-23 | 1996-02-28 | Sanyo Chemical Industries Ltd. | Surgical adhesive sheet |
US4994208A (en) * | 1989-04-18 | 1991-02-19 | Ppg Industries, Inc. | Photochromic polymeric article |
US5487897A (en) * | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
US5574104A (en) * | 1990-01-05 | 1996-11-12 | The B. F. Goodrich Company | Chain extended low molecular weight polyoxiranes and electrostatic dissipating blend compositions based thereon |
US5204110A (en) * | 1990-05-02 | 1993-04-20 | Ndm Acquisition Corp. | High absorbency hydrogel wound dressing |
US5166300A (en) * | 1990-07-20 | 1992-11-24 | Lord Corporation | Non-yellowing polyurethane adhesives |
US5389718A (en) * | 1990-07-30 | 1995-02-14 | Miles Inc. | Two-component aqueous polyurethane dispersions |
JPH04150866A (ja) | 1990-10-15 | 1992-05-25 | Nisshinbo Ind Inc | 外科用接着剤 |
JP2928892B2 (ja) | 1990-11-27 | 1999-08-03 | 三洋化成工業株式会社 | 外科用接着剤 |
US5175228A (en) * | 1991-12-09 | 1992-12-29 | Gencorp Inc. | Two-component primerless urethane-isocyanurate adhesive compositions having high temperature resistance |
CA2083741A1 (en) * | 1992-01-24 | 1993-07-25 | James Anthony Braatz | Protein nonadsorptive membranes for wound dressings |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
EP0648237B1 (en) * | 1992-06-26 | 1997-11-05 | Minnesota Mining And Manufacturing Company | Polyurethane/polyurea elastomers |
DE4315173A1 (de) | 1992-12-23 | 1994-06-30 | Bayer Ag | Reine, insbesondere katalysatorfreie Polyurethane |
US5346981A (en) * | 1993-01-13 | 1994-09-13 | Miles Inc. | Radiopaque polyurethanes |
GB9306887D0 (en) * | 1993-04-01 | 1993-05-26 | Graham Neil B | Random block copolymers |
DE4407490A1 (de) * | 1994-03-07 | 1995-09-14 | Bayer Ag | Verfahren zur Herstellung heißhärtender Einkomponenten-Polyurethan-Reaktivmassen |
AU1999995A (en) * | 1994-04-08 | 1995-11-10 | Atrix Laboratories, Inc. | An adjunctive polymer system for use with medical device |
US5578662A (en) * | 1994-07-22 | 1996-11-26 | United States Surgical Corporation | Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom |
DE69530928T2 (de) * | 1994-08-22 | 2003-12-24 | Zeon Corp | Gegenstand aus polyurethane in einer tubularen ballon form |
BR9607155A (pt) * | 1995-01-13 | 1997-11-11 | Essex Specialty Prod | Composição adesiva bicomponente processo para ligar dois substratos entre si |
US5618850A (en) * | 1995-03-09 | 1997-04-08 | Focal, Inc. | Hydroxy-acid cosmetics |
US5900245A (en) * | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
US5780573A (en) * | 1995-06-13 | 1998-07-14 | Kuraray Co., Ltd. | Thermoplastic polyurethanes and molded articles comprising them |
US6103850A (en) * | 1995-12-29 | 2000-08-15 | Basf Corporation | Sealants made using low unsaturation polyoxyalkylene polyether polyols |
US5922809A (en) * | 1996-01-11 | 1999-07-13 | The Dow Chemical Company | One-part moisture curable polyurethane adhesive |
US5948427A (en) * | 1996-04-25 | 1999-09-07 | Point Medical Corporation | Microparticulate surgical adhesive |
US5791352A (en) * | 1996-06-19 | 1998-08-11 | Fusion Medical Technologies, Inc. | Methods and compositions for inhibiting tissue adhesion |
DE19624641A1 (de) * | 1996-06-20 | 1998-01-08 | Biotec Biolog Naturverpack | Biologisch abbaubarer Werkstoff, bestehend im wesentlichen aus oder auf Basis thermoplastischer Stärke |
US6566406B1 (en) * | 1998-12-04 | 2003-05-20 | Incept, Llc | Biocompatible crosslinked polymers |
US7009034B2 (en) * | 1996-09-23 | 2006-03-07 | Incept, Llc | Biocompatible crosslinked polymers |
US5990237A (en) * | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
US5900473A (en) * | 1997-06-16 | 1999-05-04 | H.B. Fuller Licensing & Financing, Inc. | Radiation curable pressure sensitive adhesives |
US6162241A (en) | 1997-08-06 | 2000-12-19 | Focal, Inc. | Hemostatic tissue sealants |
US6043313A (en) * | 1997-09-04 | 2000-03-28 | Eastman Chemical Company | Thermoplastic polyurethane additives for improved polymer matrix composites and methods of making and using therefor |
US5869566A (en) * | 1997-09-24 | 1999-02-09 | Ppg Industries, Inc. | Rapid drying, isocyanate cured coating composition with improved adhesion |
US6154089A (en) * | 1997-12-05 | 2000-11-28 | Texas Instruments Incorporated | Fast bus driver with reduced standby power consumption |
DE69928511T2 (de) * | 1998-03-31 | 2006-08-10 | Sekisui Chemical Co., Ltd. | Polyesterurethan-elastomere und verfahren zu deren herstellung |
JP4132244B2 (ja) * | 1998-07-06 | 2008-08-13 | 株式会社クラレ | 熱可塑性ポリウレタンからなるポリウレタン弾性繊維およびその製造方法 |
US6297349B1 (en) * | 1998-08-25 | 2001-10-02 | Union Carbide Chemicals & Plastics Technology Corporation | Condensation copolymers having supressed crystallinity |
JP2002535046A (ja) | 1999-01-22 | 2002-10-22 | セント・ジュード・メディカル・インコーポレーテッド | 基質/接着剤成分複合体 |
DE60010050T2 (de) * | 1999-02-05 | 2005-07-14 | Essex Epecialty Products Llc, Auburn Hills | Polyurethandichtungszusammensetzung |
US6312725B1 (en) * | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
DE19924092A1 (de) * | 1999-05-26 | 2000-11-30 | Bayer Ag | Adhäsionsstabiles Verbundmaterial aus Polyurethan und einem weiteren thermoplastischen Material, ein Verfahren zu dessen Herstellung sowie dessen Verwendung in Kraftfahrzeugen |
AU5325000A (en) * | 1999-06-05 | 2000-12-28 | David Houze | Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use |
ATE434010T1 (de) | 1999-08-27 | 2009-07-15 | Angiodevice Internat Gmbh | Interpenetrierende polymernetzwerke zur verwendung als hochfeste medizinische dichtungsmasse |
WO2001019887A1 (fr) * | 1999-09-10 | 2001-03-22 | Mitsui Chemicals, Inc. | Resine de polyuretane biodegradable |
US6565969B1 (en) * | 1999-10-21 | 2003-05-20 | 3M Innovative Properties Company | Adhesive article |
US20030035786A1 (en) * | 1999-11-04 | 2003-02-20 | Medtronic, Inc. | Biological tissue adhesives, articles, and methods |
US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
US6395112B1 (en) * | 2000-02-04 | 2002-05-28 | The United States Of America As Represented By The Secretary Of The Navy | Hydrolyzable polymers for explosive and propellant binders |
CA2402790A1 (en) * | 2000-04-06 | 2001-10-18 | University Technology Corporation | Compositions and methods for promoting wound healing |
US6576702B2 (en) * | 2000-07-20 | 2003-06-10 | Noveon Ip Holdings Corp. | Plasticized waterborne polyurethane dispersions and manufacturing process |
US6605666B1 (en) * | 2000-07-27 | 2003-08-12 | 3M Innovative Properties Company | Polyurethane film-forming dispersions in alcohol-water system |
JP2002060341A (ja) | 2000-08-21 | 2002-02-26 | Terumo Corp | 止血剤 |
US6524327B1 (en) * | 2000-09-29 | 2003-02-25 | Praxis, Llc | In-situ bonds |
AU2002249826A1 (en) | 2000-12-22 | 2002-07-30 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
GB0100760D0 (en) * | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
US20030044380A1 (en) * | 2001-07-19 | 2003-03-06 | Zhu Yong Hua | Adhesive including medicament |
EP1418925A4 (en) | 2001-07-31 | 2009-09-02 | Tyco Healthcare | BIOLOGICALLY RESORBABLE ADHESIVE COMPOSITIONS AND COMPOSITIONS |
US20040068078A1 (en) * | 2001-12-12 | 2004-04-08 | Milbocker Michael T. | In situ polymerizing medical compositions |
US8501165B2 (en) * | 2001-12-12 | 2013-08-06 | Promethean Surgical Devices Llc | In situ bonds |
US20050131192A1 (en) * | 2001-12-18 | 2005-06-16 | Takehisa Matsuda | Polymer and process for producing polymer |
DE10163857A1 (de) | 2001-12-22 | 2003-07-10 | Henkel Kgaa | Reaktive Polyurethane mit einem geringen Gehalt an monomeren Diisocyanaten |
US7264823B2 (en) * | 2002-02-08 | 2007-09-04 | University Of Pittsburgh | Medical adhesive and methods of tissue adhesion |
US6824703B2 (en) * | 2002-03-08 | 2004-11-30 | Bayer Materialscience Llc | Polyurethane elastomers having improved physical properties and a process for the production thereof |
US6897281B2 (en) * | 2002-04-05 | 2005-05-24 | Noveon Ip Holdings Corp. | Breathable polyurethanes, blends, and articles |
US6972315B2 (en) * | 2002-07-19 | 2005-12-06 | Gross Richard A | Enzyme-catalyzed polycondensations |
DE10309368A1 (de) | 2002-08-06 | 2004-02-26 | Aventis Behring Gmbh Intellectual Property/Legal | Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase |
CN1166715C (zh) * | 2002-08-23 | 2004-09-15 | 清华大学 | 一种可生物降解聚氨酯弹性体的合成 |
CA2499447C (en) | 2002-10-28 | 2011-03-29 | Tyco Healthcare Group Lp | Fast curing compositions |
DE60328120D1 (de) | 2002-10-28 | 2009-08-06 | Tyco Healthcare | Biologisch absorbierbare adhäsive verbindungen |
AU2003284196A1 (en) | 2002-10-31 | 2004-06-07 | Dow Global Technologies Inc. | Polyurethane dispersion and articles prepared therefrom |
US20040198944A1 (en) * | 2003-03-04 | 2004-10-07 | Meltzer Donald A. | Thermoplastic polyurethanes |
IL155866A0 (en) * | 2003-05-12 | 2003-12-23 | Yissum Res Dev Co | Responsive polymeric system |
US20040242831A1 (en) | 2003-05-30 | 2004-12-02 | Dong Tian | Enzyme catalyzed polyesters and polyol polymers |
US7632294B2 (en) * | 2003-09-29 | 2009-12-15 | Promethean Surgical Devices, Llc | Devices and methods for spine repair |
US7163920B2 (en) | 2003-09-30 | 2007-01-16 | Ethicon, Inc. | Peptide with osteogenic activity |
US7514503B2 (en) * | 2003-10-08 | 2009-04-07 | Asahi Kasei Chemicals Corporation | Molded article produced from aliphatic polyester resin composition |
WO2005051483A2 (en) * | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Electrical devices and anti-scarring agents |
US20050129733A1 (en) * | 2003-12-09 | 2005-06-16 | Milbocker Michael T. | Surgical adhesive and uses therefore |
US8309112B2 (en) * | 2003-12-24 | 2012-11-13 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same |
WO2005100429A1 (en) | 2004-04-15 | 2005-10-27 | The University Of Utah Research Foundation | Bioresponsive polymer system for delivery of microbicides |
US20050266086A1 (en) | 2004-06-01 | 2005-12-01 | Sawhney Amarpreet S | Intrauterine applications of materials formed in situ |
CA2574933C (en) | 2004-07-26 | 2015-05-19 | Synthes (U.S.A.) | Biocompatible, biodegradable polyurethane materials with controlled hydrophobic to hydrophilic ratio |
WO2007001448A2 (en) | 2004-11-04 | 2007-01-04 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
WO2006084911A2 (en) | 2005-02-11 | 2006-08-17 | Nolabs Ab | Improved device for application of medicaments, manufacturing method therefor, and method of treatment |
CA2600085A1 (en) | 2005-03-09 | 2006-09-14 | Toray Industries, Inc. | Microparticle and pharmaceutical preparation |
CN101189016B (zh) | 2005-04-04 | 2013-03-27 | 因特尔赛克特耳鼻喉公司 | 治疗鼻窦病症的装置 |
US8044234B2 (en) | 2005-05-05 | 2011-10-25 | Tyco Healthcare Group Lp | Bioabsorbable surgical composition |
EP1888131A2 (en) | 2005-06-01 | 2008-02-20 | NOLabs AB | Treatment and pre-treatment device, and manufacturing method therefor, involving nitric oxide |
ITMO20050139A1 (it) | 2005-06-03 | 2006-12-04 | Tartarica Treviso S R L | Materie plastiche biodegradabili. |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
-
2006
- 2006-12-06 JP JP2008544473A patent/JP5088894B2/ja not_active Expired - Fee Related
- 2006-12-06 AU AU2006321913A patent/AU2006321913B2/en not_active Ceased
- 2006-12-06 CA CA 2628582 patent/CA2628582C/en not_active Expired - Fee Related
- 2006-12-06 WO PCT/US2006/046554 patent/WO2007067623A2/en active Application Filing
- 2006-12-06 EP EP06844892A patent/EP1968617A4/en not_active Withdrawn
- 2006-12-06 US US11/635,294 patent/US7998466B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7998466B2 (en) | 2011-08-16 |
CA2628582A1 (en) | 2007-06-14 |
EP1968617A4 (en) | 2012-05-02 |
WO2007067623A3 (en) | 2008-02-07 |
US20070128152A1 (en) | 2007-06-07 |
AU2006321913A1 (en) | 2007-06-14 |
CA2628582C (en) | 2015-03-31 |
WO2007067623A2 (en) | 2007-06-14 |
AU2006321913B2 (en) | 2012-08-02 |
JP2009518128A (ja) | 2009-05-07 |
EP1968617A2 (en) | 2008-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5088894B2 (ja) | 生体適合性組織封止剤および接着剤 | |
EP2002850B1 (en) | Adhesive formulations | |
AU2006321911B2 (en) | Biocompatible surgical compositions | |
CA2595633C (en) | Synthetic sealants | |
US7858078B2 (en) | Bioabsorbable surgical composition | |
CA2630327C (en) | Biocompatible surgical compositons | |
AU2006321856B2 (en) | Biocompatible surgical compositions | |
JP2010188132A (ja) | 接着処方物 | |
CA2628580C (en) | Bioabsorbable compounds and compositions containing them | |
US20110123476A1 (en) | Adhesive Formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091001 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091001 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100929 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120518 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120807 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120905 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120907 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150921 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |